@article{ref1,
title="Near-fatal gamma-butyrolactone intoxication--first report in the UK",
journal="Human and experimental toxicology",
year="2001",
author="Dupont, P. and Thornton, J.",
volume="20",
number="1",
pages="19-22",
abstract="Gamma-hydroxybutyrate (GHB) is a compound used in the treatment of alcohol withdrawal, narcolepsy, and for induction of anaesthesia. It is also contained in many products illegally marketed as &quot;dietary supplements&quot; and is increasingly being recognised as a potential drug of abuse. We report the case of a 44-year-old man who suffered coma and life-threatening respiratory depression following an accidental overdose of the GHB prodrug, gamma-butyrolactone (GBL), contained in a &quot;health drink&quot;. He made a full recovery following appropriate supportive treatment. GHB toxicity should be included in the differential diagnosis of patients with altered mental state, particularly where there is a history of recreational drug abuse.<p /><p>Language: en</p>",
language="en",
issn="0960-3271",
doi="",
url="http://dx.doi.org/"
}